Comparison of telomerase activity in malignant and benign pleural effusions

Tanaffos

Volumn 8, Issue 2, 2009, Pages 17-23

  Mousavi, Seyed Alijavad ^a   Bahari, Rasoul ^a   Karimi, Mohammad Ali ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lung cancer; Pleural effusion; Telomerase

Indexed keywords

TELOMERASE;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LUNG CANCER; LUNG EMBOLISM; LUNG LYMPHOMA; LYMPHOMA; MALE; METASTASIS; PLEURA EFFUSION; PNEUMONIA; PREDICTOR VARIABLE; SENSITIVITY AND SPECIFICITY; SUPERIOR CAVA VEIN SYNDROME; TUBERCULOSIS;

EID: 77953468166     PISSN: 17350344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hiyama E, Hiyama K. Telomerase as tumor marker. Cancer Lett 2003; 194 (2): 221-33.
2. Lingner J, Cooper JP, Cech TR. Telomerase and DNA end replication: no longer a lagging strand problem? Science 1995; 269 (5230): 1533-4.
3. Weinstein BS, Ciszek D. The reserve-capacity hypothesis: evolutionary origins and modern implications of the trade-off between tumor-suppression and tissue-repair. Exp Gerontol 2002; 37 (5): 615-27.
4. Dhaene K, Van Marck E, Parwaresch R. Telomeres, telomerase and cancer: an up-date. Virchows Arch 2000; 437 (1): 1-16.
5. Shay JW, Gazdar AF. Telomerase in the early detection of cancer. J Clin Pathol 1997; 50 (2): 106-9.
6. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995; 87 (12): 895-902.
7. Hiyama E, Hiyama K. Clinical utility of telomerase in cancer. Oncogene 2002; 21 (4): 643-9.
8. Dikmen G, Dikmen E, Kara M, Sahin E, Doǧan P, Ozdemir N. Diagnostic implications of telomerase activity in pleural effusions. Eur Respir J 2003; 22 (3): 422-6.
9. Dikmen E, Kara M, Dikmen G, Cakmak H, Dogan P. Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer. Eur J Cardiothorac Surg 2003; 23 (2): 194-9; discussion 199-20.
10. Lee JC, Jong HS, Yoo CG, Han SK, Shim YS, Kim YW. Telomerase activity in lung cancer cell lines and tissues. Lung Cancer 1998; 21 (2): 99-103.
11. Hara H, Yamashita K, Shinada J, Yoshimura H, Kameya T. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer. Lung Cancer 2001; 34 (2): 219-26.
12. Braunschweig R, Guilleret I, Delacrétaz F, Bosman FT, Mihaescu A, Benhattar J. Pitfalls in TRAP assay in routine detection of malignancy in effusions. Diagn Cytopathol 2001; 25 (4): 225-30.
13. Yang Z, Xie C. Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions. Zhonghua Jie He He Hu Xi Za Zhi 2001; 24 (4): 201-3.
14. Dejmek A, Yahata N, Ohyashiki K, Ebihara Y, Kakihana M, Hirano T, et al. In situ telomerase activity in pleural effusions: a promising marker for malignancy. Diagn Cytopathol 2001; 24 (1): 11-5.
15. Alani B, Zarghami N, Ansarin KH, Rafat SN, Mohajeri SA. Sensitivity and specificity of tumor markers, telomerase, PTH, CEA and Cyfra21-1 in diagnosis of lung cancer. Feyz 2007; 11 (2); 22-28
16. Dhaene K, Hübner R, Kumar-Singh S, Weyn B, Van Marck E. Telomerase activity in human pleural mesothelioma. Thorax 1998; 53 (11): 915-8.
17. Sutnida T, Sogawa K, Hamakawa H, Sugita A, Tanioka H, Ueda N. Detection of telomerase activity in oral lesions. J Oral Pathol Med 1998; 27 (3): 111-5.
18. Yang CT, Lee MH, Lan RS, Chen JK. Telomerase activity in pleural effusions: diagnostic significance. J Clin Oncol 1998; 16 (2): 567-73.
19. Toshima S, Arai T, Yasuda Y, Takaya T, Ito Y, Hayakawa K, et al. Cytological diagnosis and telomerase activity of cells in effusions of body cavities. Oncol Rep 1999; 6 (1): 199-203.
20. Spangler EA, Rogers KS, Thomas JS, Pustejovsky D, Boyd SL, Shippen DE. Telomerase enzyme activity as a diagnostic tool to distinguish effusions of malignant and benign origin. J Vet Intern Med 2000; 14 (2): 146-50.
21. Sen S, Reddy VG, Khanna N, Guleria R, Kapila K, Singh N. A comparative study of telomerase activity in sputum, bronchial washing and biopsy specimens of lung cancer. Lung Cancer 2001; 33 (1): 41-9.
22. Cunningham VJ, Markham N, Shroyer AL, Shroyer KR. Detection of telomerase expression in fine-needle aspirations and fluids. Diagn Cytopathol 1998; 18 (6): 431-6.
23. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996; 8 (1): 66-71.
24. Zheng PS, Iwasaka T, Yamasaki F, Ouchida M, Yokoyama M, Nakao Y, et al. Telomerase activity in gynecologic tumors. Gynecol Oncol 1997; 64 (1): 171-5.
25. Nagel H, Schiott T, Schulz GM, Droese M. Gene expression analysis of the catalytic subunit of human telomerase (hEST2) in the differential diagnosis of serous effusions. Diagn Mol Pathol 2001; 10 (1): 60-5.
26. Zendehrokh N, Rehnberg J, Dejmek A. Comparison of NCL-hTERT antibody reactivity and telomere repeat amplification protocol in situ in effusions. Acta Cytol 2007; 51 (6): 886-92.
27. Dhaene K, Hübner R, Kumar-Singh S, Weyn B, Van Marck E. Telomerase activity in human pleural mesothelioma. Thorax 1998; 53 (11): 915-8.
28. Braunschweig R, Yan P, Guilleret I, Delacretaz F, Bosman FT, Mihaescu A, et al. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination. Diagn Cytopathol 2001; 24 (3): 174-80.
29. Mu XC, Brien TP, Ross JS, Lowry CV, McKenna BJ. Telomerase activity in benign and malignant cytologic fluids. Cancer 1999; 87 (2): 93-9.
30. Dhaene K, Wauters J, Weyn B, Timmermans JP, van Marck E. Expression profile of telomerase subunits in human pleural mesothelioma. J Pathol 2000; 190 (1): 80-5.